Is Halozyme Therapeutics, Inc. technically bullish or bearish?

Nov 02 2025 11:17 AM IST
share
Share Via
As of October 31, 2025, Halozyme Therapeutics, Inc. shows a mildly bullish technical trend, supported by a bullish monthly MACD and KST, despite some mixed signals from the weekly MACD and OBV indicating potential selling pressure.
As of 31 October 2025, the technical trend for Halozyme Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is bullish, indicating mixed momentum. The daily moving averages are mildly bullish, suggesting some short-term strength. The Bollinger Bands show a sideways trend on the weekly chart but are mildly bullish on the monthly chart. KST and Dow Theory are both bullish across weekly and monthly time frames, reinforcing a generally positive outlook. However, the weekly OBV is mildly bearish, which could indicate some selling pressure. Overall, the technical stance is mildly bullish, with key indicators such as the monthly MACD and KST supporting this view. Unfortunately, multi-period return data is not available for comparison with the S&P 500.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News